Spascas M 80mg/250mg Tablet
Marketer
Cassopeia Pharmaceuticals Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Spascas M 80mg/250mg Tablet
Relief-M 80mg/250mg tablets combine medications to alleviate abdominal pain. This formulation effectively reduces pain, bloating, discomfort, and cramping by relaxing stomach and intestinal muscles and inhibiting pain-causing neurotransmitters. Relief-M should be taken with food, following your doctor's prescribed dosage and duration. Dosage depends on individual needs and response. Continue treatment as directed; premature discontinuation may cause symptom recurrence or worsening. Inform your physician of all other medications, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach pain, dry mouth, appetite loss, thirst, and heartburn; these are usually temporary. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until effects are known. Alcohol should be avoided due to increased dizziness risk. Prior to use, inform your doctor of pregnancy, pregnancy plans, breastfeeding, or kidney/liver conditions to ensure appropriate dosage.
Primary Ingredients of Spascas M 80mg/250mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Spascas M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Spascas M 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Spascas M 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Spascas M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Spascas M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Spascas M 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Spascas M 80mg/250mg Tablet works:
Combiflam 80mg/250mg tablets contain Drotaverine and Mefenamic Acid, providing relief from abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), reduces abdominal pain and inflammation by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Spascas M 80mg/250mg Tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Spascas M 80mg/250mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Spascas M 80mg/250mg Tablet with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Spascas M 80mg/250mg Tablets, a potential side effect of this medication, as it can induce dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Spascas M 80mg/250mg tablets, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication; a physician's consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Spascas M 80mg/250mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Spascas M 80mg/250mg Tablet :
Should you forget to take your Spascas M 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spascas M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
3,018 People bought this recently